Anne Elizabeth O'Donnell

Anne O'Donnell practices at Medstar Medical Group II in Arlington, Virginia.

Anne O'Donnell's NPI, 1629066899, was assigned on October 11, 2005. Anne O'Donnell graduated from Georgetown University School of Medicine in 1982. Anne O'Donnell holds District of Columbia license 16633.

Anne O'Donnell's primary practice is Medstar Medical Group II, at 2000 15th N St, Arlington, VA 22201 in Arlington County. The practice phone is (443) 444-5606.

Anne O'Donnell's primary practice is Medstar Medical Group II in Arlington, Virginia. Anne O'Donnell is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Anne O'Donnell to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Anne O'Donnell practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Anne O'Donnell's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Anne O'Donnell is licensed in District of Columbia.

CMS data shows 1,140 Medicare services from Anne O'Donnell across 14 procedure codes in 2024, for 568 Medicare patients. Medicare paid $97,603 for them.

CMS counts 568 Medicare patients who saw Anne O'Donnell in 2024. The largest group is 75 to 84, with 242 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Anne O'Donnell's median patient age at 63, with 57% women.

In 2024, Anne O'Donnell wrote 1,182 Medicare Part D claims for 235 patients. 56% of them were for generic drugs. CMS names the drug for 938 of them, across 29 drugs with 11 or more claims each, at $468,427 in total drug cost. In 2023, CMS named 736 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Anne O'Donnell for performance year 2024, reported as part of a group. Anne O'Donnell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Anne O'Donnell as offering telehealth.

Dmand AI links 31 papers to Anne O'Donnell, published from 2012 to 2025. 2014 was the busiest year, with 5. The most frequent topics are Bronchiectasis, Anti-Bacterial Agents and Administration, Inhalation. Anne O'Donnell has published most often in Chronic Obstr Pulm Dis. Anne O'Donnell's most frequent co-authors are Timothy R. Aksamit, MD, Mark L. Metersky, MD and Kevin Loring Winthrop, MD.

Dmand AI links Anne O'Donnell to 4 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Mycobacterium Infections, Nontuberculous, Mycobacterium avium-intracellulare Infection and Bronchiectasis.

CMS Open Payments shows 130 general payments to Anne O'Donnell from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. Xellia Pharmaceuticals paid the most, $35,347. It also lists 5 research payments totaling $357 from 2022 to 2025.

Anne O'Donnell graduated from Georgetown University School of Medicine in 1982.